Curing HIV: Seeking to Target and Clear Persistent Infection-Reference-Cited by-同舟云学术

Curing HIV: Seeking to Target and Clear Persistent Infection

Published:2020-04 Issue:1 Volume:181 Page:189-206
ISSN:0092-8674
Container-title:Cell
language:en
Short-container-title:Cell

Author:

Margolis David M.^ORCID,Archin Nancie M.,Cohen Myron S.,Eron Joseph J.,Ferrari Guido,Garcia J. Victor,Gay Cynthia L.,Goonetilleke Nilu,Joseph Sarah B.,Swanstrom Ronald,Turner Anne-Marie W.,Wahl Angela

Funder

National Institutes of Health

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference150 articles.

1. The replication-competent HIV-1 latent reservoir is primarily established near the time of therapy initiation;Abrahams;Sci. Transl. Med.,2019

2. Myeloid and CD4 T Cells Comprise the Latent Reservoir in Antiretroviral Therapy-Suppressed SIVmac251-Infected Macaques;Abreu;MBio,2019

3. Human Immunodeficiency Virus (HIV)-Infected CCR6+ Rectal CD4+ T Cells and HIV Persistence On Antiretroviral Therapy;Anderson;J. Infect. Dis.,2020

4. Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy;Archin;Nature,2012

5. Interval dosing with the HDAC inhibitor vorinostat effectively reverses HIV latency;Archin;J. Clin. Invest.,2017

Cited by 141 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Human immunodeficiency virus/acquired immunodeficiency syndrome in the infant;Remington and Klein's Infectious Diseases of the Fetus and Newborn Infant;2025

2. Analysis of the effect of HDAC inhibitors on the formation of the HIV reservoir;mBio;2024-09-11

3. Release of P-TEFb from the Super Elongation Complex promotes HIV-1 latency reversal;PLOS Pathogens;2024-09-11

4. Delving deeper into the mechanisms fundamental to HIV-associated immunopathology using single-cell sequencing techniques: A scoping review of current literature;Heliyon;2024-08

5. MAdCAM-1 co-stimulation combined with retinoic acid and TGF-β induces blood CD8+ T cells to adopt a gut CD101+ TRM phenotype;Mucosal Immunology;2024-08